Literature DB >> 23969954

Ncking BCR-mediated PI3K activation.

Jennifer L Cannons1, Fang Zhao, Pamela L Schwartzberg.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23969954      PMCID： PMC3807230          DOI： 10.1038/embor.2013.133

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  10 in total

Review 1.  The Nck family of adapter proteins: regulators of actin cytoskeleton.

Authors:  László Buday; Livius Wunderlich; Peter Tamás
Journal:  Cell Signal       Date:  2002-09       Impact factor: 4.315

Review 2.  Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation.

Authors:  G V Baracho; A V Miletic; S A Omori; M H Cato; R C Rickert
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

3.  Recruitment of Nck by CD3 epsilon reveals a ligand-induced conformational change essential for T cell receptor signaling and synapse formation.

Authors:  Diana Gil; Wolfgang W A Schamel; María Montoya; Francisco Sánchez-Madrid; Balbino Alarcón
Journal:  Cell       Date:  2002-06-28       Impact factor: 41.582

4.  Nck adaptors are positive regulators of the size and sensitivity of the T-cell repertoire.

Authors:  Edwige Roy; Dieudonnée Togbe; Amy D Holdorf; Dmitry Trubetskoy; Sabrina Nabti; Günter Küblbeck; Alexandra Klevenz; Annette Kopp-Schneider; Frank Leithäuser; Peter Möller; Friedhelm Bladt; Günter Hämmerling; Bernd Arnold; Tony Pawson; Anna Tafuri
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-13       Impact factor: 11.205

5.  Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase.

Authors:  Yuichi Aiba; Megumi Kameyama; Tetsuo Yamazaki; Thomas F Tedder; Tomohiro Kurosaki
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

6.  SLP-76 coordinates Nck-dependent Wiskott-Aldrich syndrome protein recruitment with Vav-1/Cdc42-dependent Wiskott-Aldrich syndrome protein activation at the T cell-APC contact site.

Authors:  Rong Zeng; Judy L Cannon; Robert T Abraham; Michael Way; Daniel D Billadeau; Julie Bubeck-Wardenberg; Janis K Burkhardt
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

7.  The proline-rich sequence of CD3epsilon controls T cell antigen receptor expression on and signaling potency in preselection CD4+CD8+ thymocytes.

Authors:  Michaël Mingueneau; Amandine Sansoni; Claude Grégoire; Romain Roncagalli; Enrique Aguado; Arthur Weiss; Marie Malissen; Bernard Malissen
Journal:  Nat Immunol       Date:  2008-04-13       Impact factor: 25.606

8.  Nck-mediated recruitment of BCAP to the BCR regulates the PI(3)K-Akt pathway in B cells.

Authors:  Angelo Castello; Mauro Gaya; Johannes Tucholski; Thomas Oellerich; Kun-Hui Lu; Anna Tafuri; Tony Pawson; Jürgen Wienands; Michael Engelke; Facundo D Batista
Journal:  Nat Immunol       Date:  2013-08-04       Impact factor: 25.606

9.  Nck recruitment to the TCR required for ZAP70 activation during thymic development.

Authors:  Aldo Borroto; Irene Arellano; Elaine P Dopfer; Marek Prouza; Miloslav Suchànek; Manuel Fuentes; Alberto Orfao; Wolfgang W Schamel; Balbino Alarcón
Journal:  J Immunol       Date:  2012-12-24       Impact factor: 5.422

Review 10.  Signaling by the phosphoinositide 3-kinase family in immune cells.

Authors:  Klaus Okkenhaug
Journal:  Annu Rev Immunol       Date:  2013-01-16       Impact factor: 28.527
  10 in total
  2 in total

1.  Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma.

Authors:  Tycel J Phillips; Andres Forero-Torres; Taimur Sher; Catherine S Diefenbach; Patrick Johnston; Moshe Talpaz; Jennifer Pulini; Li Zhou; Peggy Scherle; Xuejun Chen; Paul M Barr
Journal:  Blood       Date:  2018-04-25       Impact factor: 22.113

2.  Human B Cells Engage the NCK/PI3K/RAC1 Axis to Internalize Large Particles via the IgM-BCR.

Authors:  Niels J M Verstegen; Peter-Paul A Unger; Julia Z Walker; Benoit P Nicolet; Tineke Jorritsma; Jos van Rijssel; Robbert M Spaapen; Jelle de Wit; Jaap D van Buul; Anja Ten Brinke; S Marieke van Ham
Journal:  Front Immunol       Date:  2019-03-13       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.